EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption Dahkki Pinilla, Miriam, Mazars, Raoul, Vergé, Romain, Gorse, Leana, Paradis, Margaux, Suire, Bastien, Santoni, Karin, Robinson, Kim Samirah, Toh, Gee Ann, Prouvensier, Laure, Leon-Icaza, Stephen Adonai, Hessel, Audrey, Péricat, David, Murris, Marlène, Guet-Revillet, Hélène, Henras, Anthony, Buyck, Julien, Ravet, Emmanuel, Zhong, Franklin, Cougoule, Céline, Planès, Rémi, Meunier, Etienne

Fáttát: Viečča ollesdeavstta

Elongation factor 2 in cancer: a promising therapeutic target in protein translation Dahkki Xuechao Jia, Chuntian Huang, Fangfang Liu, Zigang Dong, Kangdong Liu

Fáttát: “…Elongation factor 2…”
Viečča ollesdeavstta

2,4-disubstituted 6-fluoroquinolines as potent antiplasmodial agents: QSAR, homology modeling, molecular docking and ADMET studies Dahkki Gideon A. Shallangwa, PhD, Aliyu W. Mahmud, MSc, Adamu Uzairu, PhD, Muhmmad T. Ibrahim, PhD

Fáttát: Viečča ollesdeavstta

Silencing eEF2K combined with sodium tanshinone ⅡA sulfonate synergistically inhibit proliferation of human lung adenocarcinoma cell line A549 Dahkki WANG Bu, YUAN Sheng-fang, ZHANG Chang-hong, YUAN Cheng, HUANG Pan-deng, ZHANG Zhi-hua, ZHAO Jian-qing

Fáttát: “…lung adenocarcinoma|eukaryotic elongation factor 2 kinase|sodium tanshinone ⅱa sulfonate|proliferation|invasion…”
Viečča ollesdeavstta